A case of myocarditis mimicking acute coronary syndrome associated with H1N1 influenza A virus infection

Turk Kardiyoloji Dernegi Arsivi

Volumn 38, Issue 8, 2010, Pages 572-575

  Şahin, Durmuş Yildiray ^a   Demir, Mesut ^a   Kurtaran, Behice ^a   Usal, Ayhan ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Acute coronary syndrome; H1N1 subtype complications; Influenza a virus; Myocarditis diagnosis therapy

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; CREATINE KINASE MB; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; GENTAMICIN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; OSELTAMIVIR; POTASSIUM; PROCALCITONIN; SODIUM; SULPERAZON; TROPONIN T; VANCOMYCIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ANTIMICROBIAL THERAPY; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; CASE REPORT; COUGHING; CREATININE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY; FEVER; HEART DILATATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HUMAN; HYPOKINESIA; INFLUENZA A (H1N1); LEUKOCYTE COUNT; LUNG INFILTRATE; MALE; MYOCARDITIS; NOSE SMEAR; POTASSIUM BLOOD LEVEL; PULSE RATE; SEDIMENTATION RATE; SINUS TACHYCARDIA; SODIUM BLOOD LEVEL; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; THORAX PAIN; THORAX RADIOGRAPHY; UREA NITROGEN BLOOD LEVEL; VOMITING;

ACUTE CORONARY SYNDROME; ANTIVIRAL AGENTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MYOCARDITIS; TREATMENT OUTCOME;

EID: 79959956346     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Myocarditis Treatment Trial (MTT) Investigators: incidence and clinical characteristics of myocarditis. Circulation 1991; 84 Suppl II: II-2.
2. Hillis LD, Lange RA, Winniford MD, Page RL. Akut miyokardit. In: Kardiyolojide Klinik Problemler El Kitabi. Çeviri editörü: Hisar İ. 5. baski, Ankara: Bilimsel Tip Yayinevi; 1995. s. 167-76.
3. Simonson L, Olson DR, Viboud C, Heiman E, Taylor RJ, Miller MA, et al. Pandemic influenza and mortality: past evidence and projections for the future. In: Knobler SL, Mack A, Mahmoud A, Lemon SM, editors. The threat of pandemic influenza: are we ready? Workshop Summary. Washington, DC: The National Academies Press; 2005. p. 89-114.
4. Bartlett JG. 2009 H1N1 Influenza - Just the facts: clinical features and epidemiology. Available from: http://www.medscape.com/viewarticle/709540.
5. Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart 1997;78:539-43. (Pubitemid 28034200)
6. Agnino A, Schena S, Ferlan G, De Luca Tupputi Schinosa L. Left ventricular pseudoaneurysm after acute influenza A myocardiopericarditis. J Cardiovasc Surg 2002;43:203-5. (Pubitemid 34461077)
7. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997;95:163-8.
8. Sarda L, Colin P, Boccara F, Daou D, Lebtahi R, Faraggi M, et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol 2001;37:786-92. (Pubitemid 32202446)
9. HA Central Committee on Infectious Disease and Emergency Responses (CCIDER). Interim guideline on anti-viral treatment, chemoprophylaxis and pneumococcal vaccination for human swine influenza/influenza A (H1N1) Infection. 21 Oct 2009. Available from: http://www.ha.org.hk/haho/ho/hsflu/Interim- Treatment-091021.pdf.
10. Interim guidance on antiviral recommendations for patients with novel influenza A (H1N1) virus infection and their close contacts. US Centers for Disease Control and Prevention. Available from: http://www.cdc.gov/h1n1flu/ recommendations.htm. Accessed 16 Aug 2009.